SCHEMBL29566997

SCHEMBL29566997

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2cc(F)cc(N3CCN(C)CC3)c2)c1C(F)(F)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD52 P43351 2/20 0.34
▸ BRD4 O60885 3/20 0.33
▸ TACR1 P25103 3/20 0.33
▸ HTR1A P08908 2/20 0.33
▸ HTR7 P34969 2/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ CTSC P53634 2/20 0.32
▸ MAP4K1 Q92918 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ FGFR4 P22455 2/20 0.31
▸ IGF1R P08069 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310530 1.00 RAD52 (0.34) RAD52BRD4TACR1HTR1AHTR7
SCHEMBL24310777 0.92 HTR1A (0.38) RAD52BRD4TACR1HTR1AHTR7
SCHEMBL29566715 0.92 HTR1A (0.38) RAD52BRD4TACR1HTR1AHTR7
SCHEMBL29566963 0.92 RAD52 (0.36) RAD52BRD4TACR1HTR1AHTR7
SCHEMBL24310187 0.92 RAD52 (0.36) RAD52BRD4TACR1HTR1AHTR7
SCHEMBL24309520 0.90 SCN9A (0.35) BRD4HTR1AHTR7JAK2
SCHEMBL29566590 0.90 SCN9A (0.35) BRD4HTR1AHTR7JAK2
SCHEMBL24310497 0.89 RAD52 (0.36) RAD52BRD4MAP4K1IGF1REGFR
SCHEMBL29567138 0.89 RAD52 (0.36) RAD52BRD4MAP4K1IGF1REGFR
SCHEMBL29567137 0.89 RAD52 (0.36) RAD52BRD4MAP4K1IGF1REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback